Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carlyle Group LP

35.63
-3.0800-7.96%
Volume:3.35M
Turnover:117.02M
Market Cap:12.87B
PE:12.86
High:36.98
Open:36.54
Low:33.02
Close:38.71
Loading ...

Carlyle Group Is Maintained at Underperform by B of A Securities

Dow Jones
·
Yesterday

CG Power Completes Acquisition of Renesas Electronics' Radio Frequency Components Business

MT Newswires Live
·
Yesterday

Stocks of Wall Street giants plunge as Trump tariff turmoil roils the finance world

Yahoo Finance
·
Yesterday

Carlyle Group Inc Reports 17.3% Stake in CommScope Holding as of March 31, 2025 VS 16.6% as of Dec 31, 2023 - SEC Filing

THOMSON REUTERS
·
03 Apr

Market Chatter: Ecopetrol Mulls Buying SierraCol Energy From Carlyle Group

MT Newswires Live
·
02 Apr

MEDIA-Ecopetrol eyes buying Carlyle’s Colombia asset SierraCol Energy to boost reserves - Bloomberg News

Reuters
·
02 Apr

CORRECTED-Global deal activity disappoints, M&A revenue falls as Trump pursues tariffs

Reuters
·
01 Apr

Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade

Zacks
·
31 Mar

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates

GlobeNewswire
·
31 Mar

CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Mar

Analysts Offer Insights on NA Companies: Nano Nuclear Energy Inc. (NNE) and CG Oncology, Inc. (CGON)

TIPRANKS
·
31 Mar

BUZZ-Bluebird bio rises on non-binding bid for up to $110.5 million

Reuters
·
31 Mar

Deals of the day-Mergers and acquisitions

Reuters
·
31 Mar

CG Oncology Files Mixed Shelf

MT Newswires Live
·
31 Mar

CG Oncology Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
29 Mar

CG Oncology Advances in Bladder Cancer Therapeutics

TIPRANKS
·
29 Mar

Bluebird bio receives non-binding bid for up to $110.5 million

Reuters
·
29 Mar

CG Oncology files automatic mixed securities shelf

TIPRANKS
·
29 Mar

Bluebird Bio Gets Rival Buyout Proposal From Ayrmid; Shares Jump After Hours

MT Newswires Live
·
29 Mar

Promising Clinical Data and Strong Financials Support Buy Rating for CG Oncology

TIPRANKS
·
29 Mar